Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2
European Journal of Cancer2014Vol. 51(1), pp. 45–54
Citations Over TimeTop 10% of 2014 papers
Stéphane Oudard, Stéphane Culine, Yann Vano, François Goldwasser, Christine Théodore, Thierry Nguyen, Éric Voog, Eugéniu Banu, Annick Vieillefond, Franck Priou, G. Deplanque, Gwénaëlle Gravis, Alain Ravaud, J.M. Vannetzel, Jean‐Pascal Machiels, Xavier Muracciole, Marie-France Pichon, Jacques‐Olivier Bay, Réza Elaidi, Corine Teghom, François Radvanyi, Philippe Beuzeboc
Related Papers
- → Pentetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy(1991)196 cited
- A phase I study of gemcitabine and carboplatin in non-small cell lung cancer.(1996)
- → The Role of Gemcitabine in First-Line Treatment of Advanced Ovarian Carcinoma(2006)15 cited
- → Carboplatin and gemcitabine in stage IV non small cell lung cancer: beyond cisplatin in palliative chemotherapy(2002)2 cited
- In vitro cytotoxicity of cisplatin combined with carboplatin on osteosarcoma cell line OS-732(2004)